(Q35295186)

7 August 2017

New Evidence-Based Treatment Approach in Behçet's Disease (English)

1 reference

7 August 2017

0 references

Erkan Alpsoy

1

0 references

publication date

5 October 2011

1 reference

Pathology Research International

7 August 2017

1 reference

7 August 2017

2012

1 reference

7 August 2017

871019

1 reference

Creative Commons Attribution 3.0 Unported

7 August 2017

start time

5 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Evaluation of current therapeutic strategies in Behçet's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Behçet's disease: an algorithmic approach to its treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Mucocutaneous lesions of Behcet's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Adalimumab for sight-threatening uveitis in Behçet's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

A double-blind trial of depot corticosteroids in Behçet's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Behçet's disease: treatment of mucocutaneous lesions.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Bilateral pulmonary artery aneurysm in Behçet syndrome: report of two operative cases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Behçet's syndrome and the nervous system

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

The efficacy and safety of 50 mg penicillin G potassium troches for recurrent aphthous ulcers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Review of the chronology of clinical manifestations in 60 patients with Behçet's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study

27 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

27 July 2018

https://api.crossref.org/works/10.1155%2F2012%2F871019

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

A double-blind trial of colchicine in Behçet's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

A controlled trial of azathioprine in Behçet's syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Common inflammatory diseases of the mouth

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Effect of cyclosporine A on the hearing loss in Behçet's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Behcet's syndrome in 32 patients in Yorkshire

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Double-blind trial of tetracycline in recurrent aphthous ulceration

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Prevalence of Behçet's disease in Istanbul, Turkey.

27 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Uveitis in Behçet disease: an analysis of 880 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Relationship between periodontal findings and Behçet's disease: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Treatment with pentoxifylline in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Endovascular therapy combined with immunosuppressive treatment for pseudoaneurysms in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Prolonged remission of neuro-Behcet disease following autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F871019

Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Systemic interferon alpha 2b treatment in Behçet's syndrome.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3189606

Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study

26 September 2018

1 reference

12 December 2020

Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease

1 reference

12 December 2020

Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study

1 reference

12 December 2020

[Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease]

1 reference

12 December 2020

Mouthrinses containing triclosan reduce the incidence of recurrent aphthous ulcers (RAU)

1 reference

12 December 2020

Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease

1 reference

12 December 2020

Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behçet uveitis

1 reference

12 December 2020

A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients

1 reference

12 December 2020

Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behçeťs disease

1 reference

12 December 2020

Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations

1 reference

12 December 2020

Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study

1 reference

12 December 2020

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

1 reference

12 December 2020

A double blind study of colchicine in Behçet's disease

1 reference

12 December 2020

Treatment of Behçet's disease

1 reference

12 December 2020

Pars plana vitrectomy in ocular Behçet's disease

1 reference

12 December 2020

The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet disease: a randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Amlexanox oral paste: a novel treatment that accelerates the healing of aphthous ulcers

1 reference

12 December 2020

Clinical manifestations of Behçet's disease: an analysis of 2147 patients

1 reference

12 December 2020

A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers

1 reference

12 December 2020

IL-17A has an important role in the acute attacks of Behçet's disease

1 reference

12 December 2020

Successful treatment of Behçet disease with pentoxifylline

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/871019

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

PubMed ID

22007346